Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
184M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
76.4M
-
Shares change
-
+4.53M
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
+$199M
-
Put/Call ratio
-
2.63
-
Number of buys
-
120
-
Number of sells
-
-61
-
Price
-
$38.85
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2018
223 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock as of Q2 2018.
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.4M shares
of 184M outstanding shares and own 41.63% of the company stock.
Largest 10 shareholders include FMR LLC (11.3M shares), FRANKLIN RESOURCES INC (5.95M shares), JANUS HENDERSON GROUP PLC (5.87M shares), BAKER BROS. ADVISORS LP (5.03M shares), WELLINGTON MANAGEMENT GROUP LLP (4.77M shares), BlackRock Inc. (4.54M shares), VANGUARD GROUP INC (4.53M shares), STATE STREET CORP (3.47M shares), FIL Ltd (2.96M shares), and ArrowMark Colorado Holdings LLC (2.22M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.